Drug Changes
Here you will find a listing of the drugs that have been changed on our drug list (formulary) for the plan year you select.
To request Medicare Part D prescription drug coverage determinations (including tiering or formulary exception requests) please use the following form:
Adthyza Tablet 120 MG Oral
Type of Change:
Drug removed - Discontinued from marketplace
Reason Changed:
Drug discontinued from marketplace
Alternative Drugs
| Drug |
Tier* |
Drug Restrictions |
Therapy Class |
| Armour Thyroid Tablet 120 MG Oral |
Tier 4 |
|
Miscellaneous Therapies (Non-FRF Drugs) |
| * Please reference your Evidence of Coverage for applicable cost-sharing. |
Adthyza Tablet 130 MG Oral
Type of Change:
Drug removed - Discontinued from marketplace
Reason Changed:
Drug discontinued from marketplace
Alternative Drugs
| Drug |
Tier* |
Drug Restrictions |
Therapy Class |
| Armour Thyroid Tablet 120 MG Oral |
Tier 4 |
|
Miscellaneous Therapies (Non-FRF Drugs) |
| * Please reference your Evidence of Coverage for applicable cost-sharing. |
Adthyza Tablet 15 MG Oral
Type of Change:
Drug removed - Discontinued from marketplace
Reason Changed:
Drug discontinued from marketplace
Alternative Drugs
| Drug |
Tier* |
Drug Restrictions |
Therapy Class |
| Armour Thyroid Tablet 15 MG Oral |
Tier 4 |
|
Miscellaneous Therapies (Non-FRF Drugs) |
| * Please reference your Evidence of Coverage for applicable cost-sharing. |
Adthyza Tablet 16.25 MG Oral
Type of Change:
Drug removed - Discontinued from marketplace
Reason Changed:
Drug discontinued from marketplace
Alternative Drugs
| Drug |
Tier* |
Drug Restrictions |
Therapy Class |
| Armour Thyroid Tablet 15 MG Oral |
Tier 4 |
|
Miscellaneous Therapies (Non-FRF Drugs) |
| * Please reference your Evidence of Coverage for applicable cost-sharing. |
Adthyza Tablet 30 MG Oral
Type of Change:
Drug removed - Discontinued from marketplace
Reason Changed:
Drug discontinued from marketplace
Alternative Drugs
| Drug |
Tier* |
Drug Restrictions |
Therapy Class |
| Armour Thyroid Tablet 30 MG Oral |
Tier 4 |
|
Miscellaneous Therapies (Non-FRF Drugs) |
| * Please reference your Evidence of Coverage for applicable cost-sharing. |
Adthyza Tablet 32.5 MG Oral
Type of Change:
Drug removed - Discontinued from marketplace
Reason Changed:
Drug discontinued from marketplace
Alternative Drugs
| Drug |
Tier* |
Drug Restrictions |
Therapy Class |
| Armour Thyroid Tablet 30 MG Oral |
Tier 4 |
|
Miscellaneous Therapies (Non-FRF Drugs) |
| * Please reference your Evidence of Coverage for applicable cost-sharing. |
Adthyza Tablet 60 MG Oral
Type of Change:
Drug removed - Discontinued from marketplace
Reason Changed:
Drug discontinued from marketplace
Alternative Drugs
| Drug |
Tier* |
Drug Restrictions |
Therapy Class |
| Armour Thyroid Tablet 60 MG Oral |
Tier 4 |
|
Miscellaneous Therapies (Non-FRF Drugs) |
| * Please reference your Evidence of Coverage for applicable cost-sharing. |
Adthyza Tablet 65 MG Oral
Type of Change:
Drug removed - Discontinued from marketplace
Reason Changed:
Drug discontinued from marketplace
Alternative Drugs
| Drug |
Tier* |
Drug Restrictions |
Therapy Class |
| Armour Thyroid Tablet 60 MG Oral |
Tier 4 |
|
Miscellaneous Therapies (Non-FRF Drugs) |
| * Please reference your Evidence of Coverage for applicable cost-sharing. |
Adthyza Tablet 90 MG Oral
Type of Change:
Drug removed - Discontinued from marketplace
Reason Changed:
Drug discontinued from marketplace
Alternative Drugs
| Drug |
Tier* |
Drug Restrictions |
Therapy Class |
| Armour Thyroid Tablet 90 MG Oral |
Tier 4 |
|
Miscellaneous Therapies (Non-FRF Drugs) |
| * Please reference your Evidence of Coverage for applicable cost-sharing. |
Adthyza Tablet 97.5 MG Oral
Type of Change:
Drug removed - Discontinued from marketplace
Reason Changed:
Drug discontinued from marketplace
Alternative Drugs
| Drug |
Tier* |
Drug Restrictions |
Therapy Class |
| Armour Thyroid Tablet 90 MG Oral |
Tier 4 |
|
Miscellaneous Therapies (Non-FRF Drugs) |
| * Please reference your Evidence of Coverage for applicable cost-sharing. |
Amoxicillin-Pot Clavulanate Tablet Chewable 400-57 MG Oral
Type of Change:
Drug removed - Discontinued from marketplace
Reason Changed:
Drug discontinued from marketplace
Alternative Drugs
| Drug |
Tier* |
Drug Restrictions |
Therapy Class |
| Amoxicillin-Pot Clavulanate Suspension Reconstituted 400-57 MG/5ML Oral |
Tier 4 |
|
Beta-lactam, Penicillins |
| * Please reference your Evidence of Coverage for applicable cost-sharing. |
Bronchitol Capsule 40 MG Inhalation
Type of Change:
Drug removed - Discontinued from marketplace
Reason Changed:
Drug discontinued from marketplace
Alternative Drugs
| Drug |
Tier* |
Drug Restrictions |
Therapy Class |
| Pulmozyme Solution 2.5 MG/2.5ML Inhalation |
Tier 5 |
PA |
Cystic Fibrosis Agents |
| * Please reference your Evidence of Coverage for applicable cost-sharing. |
Brukinsa Capsule 80 MG Oral
Type of Change:
Drug removed - Discontinued from marketplace
Reason Changed:
Drug discontinued from marketplace
Alternative Drugs
| Drug |
Tier* |
Drug Restrictions |
Therapy Class |
| Brukinsa Tablet 160 MG Oral |
Tier 5 |
PA, QL |
Molecular Target Inhibitors |
| * Please reference your Evidence of Coverage for applicable cost-sharing. |
Diphtheria-Tetanus Toxoids DT Suspension 25-5 LFU/0.5ML Intramuscular
Type of Change:
Drug removed - Discontinued from marketplace
Reason Changed:
Drug discontinued from marketplace
Alternative Drugs
| Drug |
Tier* |
Drug Restrictions |
Therapy Class |
| Tenivac Injectable 5-2 LFU Intramuscular |
Tier 3 |
|
Vaccines |
| * Please reference your Evidence of Coverage for applicable cost-sharing. |
fentaNYL Citrate Lozenge On A Handle 1200 MCG Buccal
Type of Change:
Drug removed - Discontinued from marketplace
Reason Changed:
Drug discontinued from marketplace
Alternative Drugs
| Drug |
Tier* |
Drug Restrictions |
Therapy Class |
| fentaNYL Patch 72 Hour 87.5 MCG/HR Transdermal |
Tier 4 |
QL, ST |
Opioid Analgesics, Long-acting |
| * Please reference your Evidence of Coverage for applicable cost-sharing. |
fentaNYL Citrate Lozenge On A Handle 600 MCG Buccal
Type of Change:
Drug removed - Discontinued from marketplace
Reason Changed:
Drug discontinued from marketplace
Alternative Drugs
| Drug |
Tier* |
Drug Restrictions |
Therapy Class |
| fentaNYL Patch 72 Hour 75 MCG/HR Transdermal |
Tier 4 |
QL, ST |
Opioid Analgesics, Long-acting |
| * Please reference your Evidence of Coverage for applicable cost-sharing. |
fentaNYL Citrate Tablet 100 MCG Buccal
Type of Change:
Drug removed - Discontinued from marketplace
Reason Changed:
Drug discontinued from marketplace
Alternative Drugs
| Drug |
Tier* |
Drug Restrictions |
Therapy Class |
| fentaNYL Patch 72 Hour 37.5 MCG/HR Transdermal |
Tier 4 |
QL, ST |
Opioid Analgesics, Long-acting |
| * Please reference your Evidence of Coverage for applicable cost-sharing. |
fentaNYL Citrate Tablet 200 MCG Buccal
Type of Change:
Drug removed - Discontinued from marketplace
Reason Changed:
Drug discontinued from marketplace
Alternative Drugs
| Drug |
Tier* |
Drug Restrictions |
Therapy Class |
| fentaNYL Patch 72 Hour 50 MCG/HR Transdermal |
Tier 4 |
QL, ST |
Opioid Analgesics, Long-acting |
| * Please reference your Evidence of Coverage for applicable cost-sharing. |
Gleostine CAPSULE 10 MG ORAL
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Alternative Drugs
| Drug |
Tier* |
Drug Restrictions |
Therapy Class |
| Lomustine Capsule 10 MG Oral |
Tier 4 |
|
Alkylating Agents |
| * Please reference your Evidence of Coverage for applicable cost-sharing. |
Gleostine CAPSULE 100 MG ORAL
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Alternative Drugs
| Drug |
Tier* |
Drug Restrictions |
Therapy Class |
| Lomustine Capsule 100 MG Oral |
Tier 5 |
|
Alkylating Agents |
| * Please reference your Evidence of Coverage for applicable cost-sharing. |
Gleostine CAPSULE 40 MG ORAL
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Alternative Drugs
| Drug |
Tier* |
Drug Restrictions |
Therapy Class |
| Lomustine Capsule 40 MG Oral |
Tier 4 |
|
Alkylating Agents |
| * Please reference your Evidence of Coverage for applicable cost-sharing. |
Kionex Suspension 15 GM/60ML Oral
Type of Change:
Drug removed - Discontinued from marketplace
Reason Changed:
Drug discontinued from marketplace
Alternative Drugs
| Drug |
Tier* |
Drug Restrictions |
Therapy Class |
| Lokelma Packet 10 GM Oral |
Tier 3 |
|
Potassium Binders |
| Lokelma Packet 5 GM Oral |
Tier 3 |
|
Potassium Binders |
| * Please reference your Evidence of Coverage for applicable cost-sharing. |
Ogsiveo Tablet 50 MG Oral
Type of Change:
Drug removed - Discontinued from marketplace
Reason Changed:
Drug discontinued from marketplace
Alternative Drugs
| Drug |
Tier* |
Drug Restrictions |
Therapy Class |
| Ogsiveo Tablet 100 MG Oral |
Tier 5 |
PA, QL |
Enzyme Inhibitors |
| Ogsiveo Tablet 150 MG Oral |
Tier 5 |
PA, QL |
Enzyme Inhibitors |
| * Please reference your Evidence of Coverage for applicable cost-sharing. |
PreHevbrio Suspension 10 MCG/ML Intramuscular
Type of Change:
Drug removed - Discontinued from marketplace
Reason Changed:
Drug discontinued from marketplace
Alternative Drugs
| Drug |
Tier* |
Drug Restrictions |
Therapy Class |
| Recombivax HB Suspension 10 MCG/ML Injection |
Tier 3 |
PA |
Vaccines |
| * Please reference your Evidence of Coverage for applicable cost-sharing. |
Rotarix Suspension Reconstituted Oral
Type of Change:
Drug removed - Discontinued from marketplace
Reason Changed:
Drug discontinued from marketplace
Alternative Drugs
| Drug |
Tier* |
Drug Restrictions |
Therapy Class |
| Rotarix Suspension Oral |
Tier 3 |
|
Vaccines |
| * Please reference your Evidence of Coverage for applicable cost-sharing. |
SPS Suspension 15 GM/60ML Oral
Type of Change:
Drug removed - Discontinued from marketplace
Reason Changed:
Drug discontinued from marketplace
Alternative Drugs
| Drug |
Tier* |
Drug Restrictions |
Therapy Class |
| Lokelma Packet 10 GM Oral |
Tier 3 |
|
Potassium Binders |
| Lokelma Packet 5 GM Oral |
Tier 3 |
|
Potassium Binders |
| * Please reference your Evidence of Coverage for applicable cost-sharing. |
SUMAtriptan Succinate Solution Auto-Injector 4 MG/0.5ML Subcutaneous
Type of Change:
Drug removed - Discontinued from marketplace
Reason Changed:
Drug discontinued from marketplace
Alternative Drugs
| Drug |
Tier* |
Drug Restrictions |
Therapy Class |
| SUMAtriptan Succinate Solution Auto-Injector 6 MG/0.5ML Subcutaneous |
Tier 4 |
QL |
Serotonin (5-HT) Receptor Agonist |
| * Please reference your Evidence of Coverage for applicable cost-sharing. |
TDVax Suspension 2-2 LF/0.5ML Intramuscular
Type of Change:
Drug removed - Discontinued from marketplace
Reason Changed:
Drug discontinued from marketplace
Alternative Drugs
| Drug |
Tier* |
Drug Restrictions |
Therapy Class |
| Tenivac Injectable 5-2 LFU Intramuscular |
Tier 3 |
|
Vaccines |
| * Please reference your Evidence of Coverage for applicable cost-sharing. |
Zimhi Solution Prefilled Syringe 5 MG/0.5ML Injection
Type of Change:
Drug removed - Discontinued from marketplace
Reason Changed:
Drug discontinued from marketplace
Alternative Drugs
| Drug |
Tier* |
Drug Restrictions |
Therapy Class |
| Naloxone HCl Solution Prefilled Syringe 2 MG/2ML Injection |
Tier 2 |
|
Opioid Reversal Agents |
| * Please reference your Evidence of Coverage for applicable cost-sharing. |
Dificid Tablet 200 MG Oral
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Alternative Drugs
| Drug |
Tier* |
Drug Restrictions |
Therapy Class |
| Fidaxomicin Tablet 200 MG Oral |
Tier 5 |
ST |
Macrolides |
| * Please reference your Evidence of Coverage for applicable cost-sharing. |
fentaNYL Citrate Tablet 400 MCG Buccal
Type of Change:
Drug removed - Discontinued from marketplace
Reason Changed:
Drug discontinued from marketplace
Alternative Drugs
| Drug |
Tier* |
Drug Restrictions |
Therapy Class |
| fentaNYL Patch 72 Hour 12 MCG/HR Transdermal |
Tier 4 |
QL, ST |
Opioid Analgesics, Long-acting |
| * Please reference your Evidence of Coverage for applicable cost-sharing. |
fentaNYL Citrate Tablet 600 MCG Buccal
Type of Change:
Drug removed - Discontinued from marketplace
Reason Changed:
Drug discontinued from marketplace
Alternative Drugs
| Drug |
Tier* |
Drug Restrictions |
Therapy Class |
| fentaNYL Patch 72 Hour 25 MCG/HR Transdermal |
Tier 4 |
QL, ST |
Opioid Analgesics, Long-acting |
| * Please reference your Evidence of Coverage for applicable cost-sharing. |
fentaNYL Citrate Tablet 800 MCG Buccal
Type of Change:
Drug removed - Discontinued from marketplace
Reason Changed:
Drug discontinued from marketplace
Alternative Drugs
| Drug |
Tier* |
Drug Restrictions |
Therapy Class |
| fentaNYL Patch 72 Hour 37.5 MCG/HR Transdermal |
Tier 4 |
QL, ST |
Opioid Analgesics, Long-acting |
| * Please reference your Evidence of Coverage for applicable cost-sharing. |
Ocaliva TABLET 10 MG ORAL
Type of Change:
Drug removed - Discontinued from marketplace
Reason Changed:
Drug discontinued from marketplace
Alternative Drugs
| Drug |
Tier* |
Drug Restrictions |
Therapy Class |
| Iqirvo Tablet 80 MG Oral |
Tier 5 |
PA, QL |
Gastrointestinal Agents, Other |
| * Please reference your Evidence of Coverage for applicable cost-sharing. |
Ocaliva TABLET 5 MG ORAL
Type of Change:
Drug removed - Discontinued from marketplace
Reason Changed:
Drug discontinued from marketplace
Alternative Drugs
| Drug |
Tier* |
Drug Restrictions |
Therapy Class |
| Iqirvo Tablet 80 MG Oral |
Tier 5 |
PA, QL |
Gastrointestinal Agents, Other |
| * Please reference your Evidence of Coverage for applicable cost-sharing. |
Premarin Tablet 0.3 MG Oral
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Alternative Drugs
| Drug |
Tier* |
Drug Restrictions |
Therapy Class |
| Estrogens Conjugated Tablet 0.3 MG Oral |
Tier 4 |
|
Estrogens |
| * Please reference your Evidence of Coverage for applicable cost-sharing. |
Premarin Tablet 0.45 MG Oral
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Alternative Drugs
| Drug |
Tier* |
Drug Restrictions |
Therapy Class |
| Estrogens Conjugated Tablet 0.45 MG Oral |
Tier 4 |
|
Estrogens |
| * Please reference your Evidence of Coverage for applicable cost-sharing. |
Premarin Tablet 0.625 MG Oral
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Alternative Drugs
| Drug |
Tier* |
Drug Restrictions |
Therapy Class |
| Estrogens Conjugated Tablet 0.625 MG Oral |
Tier 4 |
|
Estrogens |
| * Please reference your Evidence of Coverage for applicable cost-sharing. |
Premarin Tablet 0.9 MG Oral
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Alternative Drugs
| Drug |
Tier* |
Drug Restrictions |
Therapy Class |
| Estrogens Conjugated Tablet 0.9 MG Oral |
Tier 4 |
|
Estrogens |
| * Please reference your Evidence of Coverage for applicable cost-sharing. |
Premarin Tablet 1.25 MG Oral
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Alternative Drugs
| Drug |
Tier* |
Drug Restrictions |
Therapy Class |
| Estrogens Conjugated Tablet 1.25 MG Oral |
Tier 4 |
|
Estrogens |
| * Please reference your Evidence of Coverage for applicable cost-sharing. |
Rytary Capsule Extended Release 23.75-95 MG Oral
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Alternative Drugs
| Drug |
Tier* |
Drug Restrictions |
Therapy Class |
| Carbidopa-Levodopa ER Capsule Extended Release 23.75-95 MG Oral |
Tier 4 |
QL |
Dopamine Precursors and/or L-Amino Acid Decarboxylase Inhibitors |
| * Please reference your Evidence of Coverage for applicable cost-sharing. |
Rytary Capsule Extended Release 36.25-145 MG Oral
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Alternative Drugs
| Drug |
Tier* |
Drug Restrictions |
Therapy Class |
| Carbidopa-Levodopa ER Capsule Extended Release 36.25-145 MG Oral |
Tier 4 |
QL |
Dopamine Precursors and/or L-Amino Acid Decarboxylase Inhibitors |
| * Please reference your Evidence of Coverage for applicable cost-sharing. |
Rytary Capsule Extended Release 48.75-195 MG Oral
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Alternative Drugs
| Drug |
Tier* |
Drug Restrictions |
Therapy Class |
| Carbidopa-Levodopa ER Capsule Extended Release 48.75-195 MG Oral |
Tier 4 |
QL |
Dopamine Precursors and/or L-Amino Acid Decarboxylase Inhibitors |
| * Please reference your Evidence of Coverage for applicable cost-sharing. |
Rytary Capsule Extended Release 61.25-245 MG Oral
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Alternative Drugs
| Drug |
Tier* |
Drug Restrictions |
Therapy Class |
| Carbidopa-Levodopa ER Capsule Extended Release 61.25-245 MG Oral |
Tier 4 |
QL |
Dopamine Precursors and/or L-Amino Acid Decarboxylase Inhibitors |
| * Please reference your Evidence of Coverage for applicable cost-sharing. |